Welcome to the Bioquell Media/Press Centre. On our site you’ll find quick, easy access to Bioquell's technology and details of our global operations.
Be sure to check in regularly for the latest updates. And if you need more information, please contact Martin Whiting, Marketing Director and Press Communications on firstname.lastname@example.org or by telephone +44 (0)1264 835 835.
Complete press kits are available on request.
Bioquell welcomes clarification of biocide regulations by HSE
23 September 2016
Leading bio-decontamination experts Bioquell warmly welcomes the latest publication by the HSE highlighting the timescale for hydrogen peroxide-based biocides to be compliant.
Carbapenemase Producing Enterobacteriaceae (CPE) on the increase in Belgium
It was reported in May’s edition of Eurosurveillance that the underlying rate of CPE within Belgium has more than doubled in 3 years.
Antacid a contributor to recurrent CDI?
A team at the Mayo Clinic has conducted an evaluation of the impact of antacids – more formally known as Gastric Acid Suppression – on the rates of recurrent Clostridium difficile infection (CDI). They have found that a patient taking gastric acid suppression remedies is approx 50% more likely to experience CDI than a patient who was not.
FDA warns contaminated Rx Formulation injections put patients at risk
The Food and Drug Administration (FDA) has warned that one lot of injections made by Rx Formulations are contaminated, meaning patients could be at risk from serious infections or reactions.
Misuse and over-prescription of antibiotics prevalent problem in America
A new report from CDC Vital Signs confirms that misuse and over-prescription of antibiotics is a problem that's fast becoming rife across America.